Anterior-Inferior versus Superior Plating for Displaced Midshaft Clavicle Fractures: A Systematic Review and Meta-Analysis

Authors

  • Yousef El-Tawil
  • Umair Baig
  • Praveen Rajan
  • Saif Shehadeh
  • Vishnuga Uthayamohan
  • Bhargava Krishna Balineni
  • Malaika Menon
  • Meenakshi Bheemavarapu

Abstract

Introduction: Displaced midshaft clavicle fractures are commonly treated with plate fixation, yet the optimal plate position-superior versus anteroinferior-remains debated. Superior plating provides strong biomechanical stability but is often associated with hardware prominence, whereas anteroinferior plating may reduce implant-related irritation without compromising fixation integrity.

Methods: We conducted a systematic review and meta-analysis of randomised controlled trials comparing superior and anteroinferior plating for displaced midshaft clavicle fractures. Primary outcomes included hardware removal and functional recovery; secondary outcomes were nonunion and complications. Effect sizes were pooled using random-effects models, heterogeneity was assessed with I², and publication bias was explored using contour-enhanced funnel plots.

Results: Three trials (n = 95) met inclusion criteria. Hardware removal showed no significant difference between techniques (log RR = -0.79; 95% CI: -3.94 to 1.74; I² = 0%). Functional outcomes favoured anteroinferior plating (SMD = -0.51; 95% CI: -1.27 to 0.25), though this difference was not statistically significant, and heterogeneity was substantial (I² = 92.7%), reflecting variability in outcome measures and follow-up intervals. Nonunion rates were comparable (log RR = 0.39; 95% CI: -2.55 to 3.13; I² = 0%), with both techniques achieving union rates exceeding 95% and low complication frequencies. Superior plating remained consistently associated with greater implant prominence and irritation.

Conclusions: Both plating orientations provide reliable fracture healing and excellent long-term function. Anteroinferior plating may offer a modest advantage in reducing hardware-related morbidity and improving early functional outcomes, but evidence is limited by small sample sizes and high heterogeneity. Larger, standardised multicentre trials are needed to confirm these findings.

Downloads

Published

2025-12-11